Long-term PPI use has been linked with osteoporosis and increased fracture risk, with suggested mechanisms including calcium/B12 malabsorption, gastrin-induced parathyroid hyperplasia, and direct inhibition of osteoclastic vacuolar proton pumps [22]. This evidence concerns the gene GAST and parathyroid hyperplasia.